From pancreas and islet resources to diabetes insights
Pancreatic islets of Langerhans are central to the pathogenesis of all major forms of diabetes. The ability to study human islets ex vivo has advanced our understanding of diabetes and aided in the development of novel therapeutics. However, for decades, very few laboratories had access to this critical resource and experiments on human islets were typically underpowered. More recently, multiple consortia around the world have started to enable islet biology at scale, enriching our understanding of the intra-individual variability of islet function and disease mechanisms. This article reviews and compares existing large-scale human islet tissue and data resources, offering suggestions for their improvement and for developing new resources.
Authors
- Piero Marchetti (ORCID: https://orcid.org/0000-0003-4907-0635)
- Patrick Edward MacDonald (ORCID: https://orcid.org/0000-0002-5439-6288)
- Lorella Marselli (ORCID: https://orcid.org/0000-0002-6698-2962)
- Sarah J. Richardson (ORCID: https://orcid.org/0000-0002-1160-6062)
- Jianguo Xia (ORCID: https://orcid.org/0000-0003-2040-2624)
- Jonas Lemvig
- James D. Johnson
- Jesper G S Madsen
- Teresa Rodriguez-Calvo
- Christiana Lekka
- Miriam Cnop
- Xiaoyan Yi
- Sing-Young Chen
Institutions
- University of Pisa (IT)
- Université Libre de Bruxelles (BE)
- University of British Columbia (CA)
- University of Alberta (CA)
- University of Southern Denmark (DK)
- Lund University (SE)
- University of Exeter (GB)
- Erasmus Hospital (BE)
- Michigan Medicine (US)
- Walloon Excellence in Lifesciences and Biotechnology (BE)
- German Center for Diabetes Research (DE)
- McGill University (CA)
Publication Details
- Journal
- Diabetologia
- Published
- 2026-05-01
- DOI
- https://doi.org/10.1007/s00125-026-06731-4
- Primary Topic
- Pancreatic function and diabetes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Diabetes Canada
- Novo Nordisk Fonden
- Canadian Institutes of Health Research